Description

Methyl 5-Cyano-1-(4-Fluorophenyl)-4-Methyl-6-Oxo-1,6-Dihydro-3-Pyridazinecarboxylate is a high-purity, advanced pharmaceutical intermediate with significant synthetic utility. This compound matters for its role as a key building block in the development of novel active pharmaceutical ingredients (APIs), particularly in therapeutic areas requiring complex heterocyclic scaffolds. Pharmaceutical R&D and fine chemical synthesis teams need this material for its precise molecular architecture, which enables the construction of targeted drug candidates with potential biological activity.

Application

• Pharmaceutical Intermediate: A critical precursor in the multi-step synthesis of novel drug candidates, especially in central nervous system (CNS) and anti-inflammatory research.
• Agrochemical Research: Serves as a building block for developing new-generation herbicides and pesticides with specific mode-of-action targets.
• Chemical Biology Probe Development: Used to create tool compounds for studying enzyme function and cellular signaling pathways.
• Organic Synthesis Building Block: Utilized in academic and industrial research for constructing complex pyridazine-based heterocyclic libraries.
• Material Science Research: Investigated as a potential monomer or precursor for specialty polymers and advanced organic materials.

Basic Information

Product Name	Methyl 5-Cyano-1-(4-Fluorophenyl)-4-Methyl-6-Oxo-1,6-Dihydro-3-Pyridazinecarboxylate
CAS No.	339018-13-2
Molecular Formula	C14H10FN3O3
Molecular Weight	287.25 g/mol
Synonyms	Methyl 5-cyano-1-(4-fluorophenyl)-4-methyl-6-oxo-1,6-dihydropyridazine-3-carboxylate; 1,6-Dihydro-5-cyano-1-(4-fluorophenyl)-4-methyl-6-oxo-3-pyridazinecarboxylic Acid Methyl Ester; 3-Pyridazinecarboxylic acid, 5-cyano-1-(4-fluorophenyl)-1,6-dihydro-4-methyl-6-oxo-, methyl ester; Methyl 1-(4-fluorophenyl)-5-cyano-4-methyl-6-oxo-1,6-dihydro-3-pyridazinecarboxylate; CAS 339018-13-2
EINECS	Contact for details

Quality Control

Our Methyl 5-Cyano-1-(4-Fluorophenyl)-4-Methyl-6-Oxo-1,6-Dihydro-3-Pyridazinecarboxylate is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and MS, to ensure identity, purity, and consistency. Certificates of Analysis (COA) are provided with every shipment, detailing all critical quality attributes. We support compliance with cGMP and ICH Q7 guidelines for pharmaceutical intermediates.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (15-25°C). This material is hygroscopic (moisture-sensitive); keep the original container tightly sealed in a dry environment to prevent degradation. Keep away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time matches reference standard
Purity (HPLC)	≥ 98.0%
Water Content (KF)	≤ 0.5%
Residue on Ignition	≤ 0.1%
Heavy Metals	≤ 10 ppm

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.